Researchers at the Heidelberg Faculty of Medicine at Heidelberg University have deciphered the molecular mechanism by which the widely used chemotherapy drug doxorubicin can damage the heart. In preclinical studies, another approved cancer drug provided protection. The findings have been published in „Nature Communications“.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Möglichen Ansatz zum Schutz des Herzens bei bestimmter Chemotherapie entdeckt | 0 | 7.66 | 21-09-2026 |
| 2 | UIC research: A cancer drug that treats herpes, too | 0 | 10.41 | 24-03-2026 |
| 3 | Cardiotoxicity of Immune Checkpoint Inhibitors | 0 | 8 | 01-10-2024 |
| 4 | がん細胞が酸化ストレスから身を守り生存する仕組みを発見-防御を断ち細胞死を促進する新たながん治療標的として期待- | 0 | 10 | 02-08-2026 |
| 5 | Team finds way to reverse ovarian cancer’s chemo resistance | 5 | 8 | 25-06-2026 |
| 6 | New Drug Turns Cancer’s Favorite Fuel Into a Deadly Weakness | 0 | 18.09 | 17-08-2026 |
| 7 | Targeted to the right place - Study: Cellular proteins guide active ingredients to diseased cells | 0 | 5.78 | 25-09-2026 |
| 8 | Российские ученые создали новый способ доставки лекарства к опухоли | 0 | 10.3 | 30-07-2026 |
| 9 | Найдена молекула, усиливающая действие химиотерапии на рак поджелудочной железы | 0 | 8.4 | 21-08-2026 |
| 10 | New study reveals how blood cancers outsmart BTK-targeted therapies | 0 | 8.1 | 28-07-2026 |